Skip to content
Peptigraph home

Peptides for Cutting

The peptides people most often research for cutting, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Peptides listed
5
With human trials
4
FDA approved (any use)
4
Searches per month
590
Showing 5 peptides · ordered by search interest for this goal
  1. TirzepatideGLP-1 / GIP dual agonistHuman RCT evidence, 4 of 4Arthritis & rheumatology 2026, PMID 41903163Human89Animal4Summarised16FDA approved (Mounjaro, Zepbound)For cuttingOverview
  2. SemaglutideGLP-1 agonistHuman RCT evidence, 4 of 4The New England journal of medicine 2025, PMID 40934115Human151Animal20Summarised14FDA approved (Ozempic, Wegovy, Rybelsus)For cuttingOverview
  3. RetatrutideGLP-1 / GIP / glucagon triple agonistHuman RCT evidence, 4 of 4The New England journal of medicine 2026, PMID 42814954Human7Animal2Summarised13Investigational · phase 3For cuttingOverview
  4. TesamorelinGHRH analogHuman RCT evidence, 4 of 4eNeurologicalSci 2026, PMID 42382101Human15Animal0Summarised10FDA approved (Egrifta)For cuttingOverview
  5. IpamorelinGHRP (ghrelin receptor agonist)No study with an outcome for cuttingPubMed search, 2 Oct 2026Human0Animal1Summarised1Not FDA approved · research chemicalOverview
Read this first

What this list does not show

Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.

Search interest is not evidence

This list follows what people search for and discuss. It says nothing about how well any peptide works.

Animal results may not carry over

Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.

Approval covers specific uses

An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.

Combinations are a separate question

Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.
Related goals

Explore nearby goals

What people search

  • cutting peptides320/mo
  • best peptides for cutting260/mo
  • peptide stack for cutting10/mo

US monthly searches, Google Keyword Planner, Oct 2026. Shown so you can see which questions this page answers.

Sources

  1. 1Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.) · 2026PMID 41903163Accessed 2 Oct 2026
  2. 2Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.The New England journal of medicine · 2025PMID 40934115Accessed 2 Oct 2026
  3. 3Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity.The New England journal of medicine · 2026PMID 42814954Accessed 2 Oct 2026
  4. 4The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.eNeurologicalSci · 2026PMID 42382101Accessed 2 Oct 2026
  5. 5PubMed search: ipamorelin[tiab] (50 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: ipamorelin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.